This is not the most recent version of the article. View current version (25 JAN 2006)

Intervention Review

You have free access to this content

Influenza vaccine for patients with chronic obstructive pulmonary disease

  1. PJ Poole,
  2. E Chacko,
  3. RWB Wood-Baker,
  4. CJ Cates

Editorial Group: Cochrane Airways Group

Published Online: 24 JUL 2000

DOI: 10.1002/14651858.CD002733


How to Cite

Poole PJ, Chacko E, Wood-Baker RWB, Cates CJ. Influenza vaccine for patients with chronic obstructive pulmonary disease. The Cochrane Database of Systematic Reviews 2000, Issue 3. Art. No.: CD002733. DOI: 10.1002/14651858.CD002733.

Author Information

*Dr Phillippa Poole, Associate Professor in Medicine, University of Auckland, Private Bag 92019, Auckland, NEW ZEALAND. p.poole@auckland.ac.nz.

Publication History

  1. Published Online: 24 JUL 2000

SEARCH

This is not the most recent version of the article. View current version (25 JAN 2006)

References

References to studies included in this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. References to ongoing studies
  4. Additional references
Cate 1977{published data only}
  • Cate TR, Kasel JA, Couch RB, Six HR, Knight V. Clinical trials of bivalent influenza/A/New Jersey/76-A/Victoria/75 vaccines in the elderly. Journal of Infectious Diseases 1977;136(Suppl):S518-25.
Fell 1977{published data only}
Gorse 1995{published data only}
  • Gorse GJ, Campbell MJ, Otto EE, Powers DC, Chambers GW, Newman FK. Increased anti-influenza A virus cytotoxic T cell activity following vaccination of the chronically elderly with live attenuated or inactivaed influenza virus vaccine. Journal of Infectious Diseases 1995;172:1-10.
Gorse 1997{published data only}
Govaert 1993{published data only}
  • Govaert ME, Dinant GJ, Aretz K, Masurel N, Sprenger MJW, Knottnerus JA. Adverse reactions to influenza vaccine in elderly people:randomised double blind placebo controlled trial. BMJ 1993;307:988-90.
Govaert 1994{published data only}
  • Govaert ME, Thijs CTMCN, Masurel N, Sprenger JW, Dinant GJ, Knottnerus JA. The efficacy of Inflenza vaccination in elderly individuals-a randomised double-blind placebo controlled trial. JAMA 1994;272(21):1661-5.
Howells 1961{published data only}
MRC 1980{published data only}
  • Advisory Group on Pulmonary Function Tests in Relation to Live Influenza Virus Vaccines. A study of live influenza virus vaccine in patients with chronic bronchitis. British Journal of Diseases of the Chest 1980;74(2):121-7.
Treanor 1992{published data only}
  • Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, et al. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Annals of Internal Medicine 1992;117:625-33.
Treanor 1994{published data only}
  • Treanor J, Dumyati G, O'Brien D, Riley M, Riley G, Erb S, et al. Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults. Journal of Infectious Diseases 1994;169:402-7.

References to studies excluded from this review

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. References to ongoing studies
  4. Additional references
Ambrosch 1979
  • Ambrosch F, Konigstein RP, Olbrich E, Potschka W, Wiedermann G. Influenza immunisation, clinical results and serological tests [Klinische und serlogische Untersuchungen zur Wirkung der Influenzaimpfung]. Aktuelle Gerontologie 1979;9:399-404.
Centanni 1997
  • Centanni S, Pregliasco F, Bonfatti C, Mensi C, Tarsia P, Guarnieri R, et al. Clinical efficacy of a vaccine-immunostimulant combination in the prevention of influenza in patients with chronic obstructive pulmonary disease. Journal of Chemotherapy 1997;9(4):273-8.
Dorrell 1997
  • Dorrell L, Hassan I, Marshall S, Chakraverty P, Ong E. Clinical and serological responses to an inactivated influenza vaccine in adults with HIV infection, diabetes, obstructive airways disease, elderly adults, and healthy volunteers. International Journal of STD and AIDS 1997;8:776-9.
Gorse 1986
  • Gorse GJ, Belse RB, Munn NJ. Safety of serum and antibody response to cold- recombinant influenza A and inactivated trivalent influenza virus vaccines in older adults with chronic diseases. Journal of Clinical Microbiology 1986;24(3):336-42.
Gorse 1988
  • Gorse GJ, Belshe RB, Munn NJ. Local and systemic antibody response in high-risk adults given live-attenuated and inactivated A virus vaccines. Journal of Clinical Microbiology 1988;26(5):911-8.
Gorse 1991
Gorse 1996
  • Gorse GJ, Otto EE, Powers DC, Chambers GW, Eickhoff CS, Newman FK. Induction of mucosal antibodies by live attenuated and inactivated influenza virus vaccines in the chronically ill elderly. Journal of Infectious Diseases 1996;173:285-90.
Howells 1975
Keitel 1993
  • Keitel WA, Couch RB, Quarles JM, Cate TR, Baxter B, Maassab HF. Trivalent attenuated cold-adapted influenza virus vaccine: reduced viral shedding and serum antibody responses in susceptible adults. Journal of Infectious Diseases 1993;167:305-11.
Lama 1998
  • Lama A, Tatliei G, Aydin Tosun G, Yildirim N. [Preventive effect of influenza vaccine on chronic obstructive pulmonary disease and bronchial asthma]. First World Congress on Vaccines and Immunisation, Istanbul, Turkey. 1998.
Margolis 1990
MRC 1959
  • Medical Research Council. Field trial of influenza virus vaccine in patients with chronic bronchitis during the winter 1957-8. BMJ 1959:905-8.
MRC 1984
  • Medical Research Council. Trials of live attenuated influenza virus vaccine in patients with chronic airways disease. British Journal of Diseases of the Chest 1984;78:236-47.
Paul 1988
  • Paul WS, Cowan J, Jackson GG. Acute respiratory illness among immunised and non-immunised patients with high-risk factors during a split season of influenza A and B. Journal of Infectious Diseases 1988;157(4):633-9.
Portari 1998
  • Portari Mancini DA, Zucatelli Mendonca RM, Zucatelli Mendonca R, Amaral do Prado J, de Meol Andrade C. Immune response to vaccine against influenza in smokers, non-smokers and in individuals holding respiratory complications. Bollettino Chimico Farmaceutico 1998;137(1):21-5.
Powers 1991
  • Powers DC, Fries LF, Murphy BR, Thumar B, Clements ML. In elderly persons live attenuated influenza A virus vaccines do not offer an advantage over inactivated virus vaccine in inducing serum or secretory antibodies or local immunologic memory. Journal of Clinical Microbiology 1991;29(3):498-505.
Prevost 1975
  • Prevost JM, Vereerstraeten-Schmerber J, Lamy F, De Koster JP. Live attenuated influenza virus vaccines in patients with chronic broncho-pulmonary diseases. Scandinavian Journal of Respiratory Diseases 1975;56:58-69.
Saah 1986
  • Saah AJ, Neufeld R, Rodstein M, La Montagne JR, Blackwelder WC, Gross P. Influenza vaccine and pneumonia mortality in a nursing home population. Archives of Internal Medicine 1986;146(12):2353-7.
Treanor 1998
Winson 1977

References to ongoing studies

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. References to ongoing studies
  4. Additional references
Gorse 2000
  • Ongoing study Starting date of trial not provided. Contact author for more information.
  • Gorse GJ. A randomised, controlled, blinded, multicentre trial to assess the efficacy of protection from natural influenza virus infection of influenza virus vaccine, trivalent, types A and B, Live, cold-adapted (CAIV-T) and inactivated influenza virus vaccine in patients with chronic obstructive pulmonary disease (COPD): A field trial. 2000.

Additional references

  1. References to studies included in this review
  2. References to studies excluded from this review
  3. References to ongoing studies
  4. Additional references
ACIP 1999
  • Advisory Committee on Immunization Practises (ACIP). Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). Morbidity & Mortality Weekly Report 1999;48(RR-4):1-28.
ATS 1995
  • ATS. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 1995;Suppl:S77-S120.
BRFSS 1998
  • Behavioural Risk Factor Surveillance System. Influenza and pneumococcal vaccination levels among adults aged > 65 years- United States 1997. Morbidity & Mortality Weekly Report 1998;47(38):797-802.
BTS 1997
  • British Thoracic Society. COPD guidelines group of the standards of care committee of the BTS.BTS Guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997;52:S7-S15.
Clark 1999
  • Clark HD, Wells GA, Huet C, McAlister FA, Salmi LR, Fergusson D, et al. Assessing the quality of randomised trials: reliabiltiy of the Jadad Scale. Controlled Clinical Trials 1999;20:448-452.
Galasso 1977
Gross 1989
Gross 1995
Jadad 1996
  • Jadad A, Moore RA, Carroll D, Jenkinson C, Reynolds JM, Gavaghan DJ, et al. Assessing the quality of reports of randomised controlled trials: is blinding necessary?. Controlled Clinical Trials 1996;17:1-12.
La Montagne 1978
  • La Montagne JR, Noble GR, Quinnan GV, Curlin GT, Blackwelder WC, Smith J, et al. Summary of clinical trials of inactivated influenza vaccine -1978. Reviews of Infectious Diseases 1983;5(4):723-36.
Moher 1996
  • Moher D, Jadad AR, Tugwell P. Assessing the quality of randomized controlled trials:current issues and future directions. nternational Journal of Technology Assessment in Health Care 1996;12:195-208.
Monto 1987
Nichol 1994
  • Nichol KL, Margolis KL, Wuorenma J, Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New England Journal of Medicine 1994;331:778-84.
Nichol 1995
  • Nichol KL, Lind A, Margolis KL, Murdoch M, McFadden R, Hauge M, et al. The effectiveness of vaccination against influenza in healthy working adults. New England Journal of Medicine 1995;333:889-93.
Nichol 1998
Nichol 1999
  • Nichol KL, Baken L, Nelson A. Relation between influenza vaccination and outpatient visits, hospitalization, and mortality in elderly persons with chronic lung disease. Annals of Internal Medicine 1999;130:397-403.
NIH 1976
  • Wright PF, Dolin R, La Montagne JR. From the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the Center for Disease Control, and the Bureau of Biologics of the Food and Drug Administration. Summary of clinical trials of influenza vaccines--II. Journal of Infectious Diseases 1976;134(6):633-8.
Patriarca 1994
Rothbart 1995
  • Rothbart PH, Kempen BM, Sprenger MJW. Sense and nonsense of influenza vaccination in asthma and chronic obstructive pulmonary disease. American Journal of Respiratory & Critical Care Medicine 1995;151:1682-6.
Siafakas 1995
  • Siafakas NM, Vermeire P, Pride NB, Paoletti P, Gibson J, Howard P, et al. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). European Respiratory Journal 1995;8:1398-1420.
Watson 1997